Evidence map›Paper›PMID 42148730›Full record

ArticleApplied and environmental microbiology2026

A programmable

Ming-Xuan Tang, Yu-Zhao Liu, Jia-Xin Liang, Ruo-Lin Huang, Xuepiao Pu, Chen-Chen Liang, Zi-Yu Tang, Tong-Tong Pei, Ya-Jie Zhao, Hao-Yu Zheng and 6 more

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ming-Xuan TangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID 0009-0007-1542-5027
Yu-Zhao LiuSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Jia-Xin LiangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Ruo-Lin HuangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xuepiao PuSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Chen-Chen LiangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Zi-Yu TangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Tong-Tong PeiSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Ya-Jie ZhaoSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Hao-Yu ZhengSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Tingting ZhangDepartment of Pathogen Biology, Base for International Science and Technology Cooperation: Carson Cancer Stem Cell Vaccines R&D Center, International Cancer Center, Shenzhen University Medical School, Shenzhen, Guangdong, China.
Zixian WuDepartment of Pathogen Biology, Base for International Science and Technology Cooperation: Carson Cancer Stem Cell Vaccines R&D Center, International Cancer Center, Shenzhen University Medical School, Shenzhen, Guangdong, China.
Ying AnSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xiaoye LiangSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xue LiuDepartment of Pathogen Biology, Base for International Science and Technology Cooperation: Carson Cancer Stem Cell Vaccines R&D Center, International Cancer Center, Shenzhen University Medical School, Shenzhen, Guangdong, China.
Tao DongSchool of Life Sciences, Guangming Advanced Research Institute, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID 0000-0003-3557-1850

Funding

Guangdong Innovative and Entrepreneurial Research Team Program 2023ZT10Y013National Natural Science Foundation of China 32530004, W2431022, 32030001National Natural Science Foundation of China W2433062National Outstanding Youth Science Fund Project of National Natural Science Foundation of China 32400096Shenzhen Medical Research Fund B2402028
6 · The paper itself

Abstract

Synthetic biology increasingly demands engineered bacterial chassis that combine robust biosynthesis with tailored functionalities. We previously developed AMAX, an

Indexed as

AeromonasMetabolic EngineeringAnimalsPlasmidsRecombinant ProteinsSynthetic BiologyRecombinant Proteinsimproved biosafetyminicellprotein expression and deliverysurface displayT6SS

Identifiers

PMID42148730
PMCPMC13274425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.